# ONCOSTING LLC: STING agonist-expressing BCG to enhance bladder cancer therapy

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | ONCOSTING LLC |
| Location | BALTIMORE, MD |
| Project | STING agonist-expressing BCG to enhance bladder cancer therapy |
| Project number | 1R44CA310037-01 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $1,030,215 |
| Awarded | 2026-09-10 |
| Project period | 2026-09-10 to 2028-08-31 |
| UEI | DJXQC89K4S79 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11312959). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.